Novel broad-spectrum activity-based probes to profile malarial cysteine proteases.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
03
2019
accepted:
17
12
2019
entrez:
11
1
2020
pubmed:
11
1
2020
medline:
21
4
2020
Statut:
epublish
Résumé
Clan CA cysteine proteases, also known as papain-like proteases, play important roles throughout the malaria parasite life cycle and are therefore potential drug targets to treat this disease and prevent its transmission. In order to study the biological function of these proteases and to chemically validate some of them as viable drug targets, highly specific inhibitors need to be developed. This is especially challenging given the large number of clan CA proteases present in Plasmodium species (ten in Plasmodium falciparum), and the difficulty of designing selective inhibitors that do not cross-react with other members of the same family. Additionally, any efforts to develop antimalarial drugs targeting these proteases will also have to take into account potential off-target effects against the 11 human cysteine cathepsins. Activity-based protein profiling has been a very useful tool to determine the specificity of inhibitors against all members of an enzyme family. However, current clan CA proteases broad-spectrum activity-based probes either target endopeptidases or dipeptidyl aminopeptidases, but not both subfamilies efficiently. In this study, we present a new series of dipeptydic vinyl sulfone probes containing a free N-terminal tryptophan and a fluorophore at the P1 position that are able to label both subfamilies efficiently, both in Plasmodium falciparum and in mammalian cells, thus making them better broad-spectrum activity-based probes. We also show that some of these probes are cell permeable and can therefore be used to determine the specificity of inhibitors in living cells. Interestingly, we show that the choice of fluorophore greatly influences the specificity of the probes as well as their cell permeability.
Identifiants
pubmed: 31923258
doi: 10.1371/journal.pone.0227341
pii: PONE-D-19-07393
pmc: PMC6953825
doi:
Substances chimiques
Antimalarials
0
Cysteine Proteinase Inhibitors
0
Molecular Probes
0
Sulfones
0
divinyl sulfone
5PFN71LP8M
Tryptophan
8DUH1N11BX
Cysteine Proteases
EC 3.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0227341Subventions
Organisme : Wellcome Trust
ID : 099950
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
FEBS J. 2017 Aug;284(16):2604-2628
pubmed: 28599096
J Exp Med. 2005 Jul 18;202(2):225-30
pubmed: 16027235
Endocr Rev. 2017 Aug 1;38(4):325-350
pubmed: 28651365
Nat Microbiol. 2018 Apr;3(4):447-455
pubmed: 29459732
PLoS Pathog. 2013 May;9(5):e1003344
pubmed: 23675297
Nat Rev Cancer. 2015 Dec;15(12):712-29
pubmed: 26597527
J Biol Chem. 2002 Dec 6;277(49):47524-32
pubmed: 12228245
Nat Rev Drug Discov. 2015 Jun;14(6):424-42
pubmed: 26000721
Trends Pharmacol Sci. 2017 Oct;38(10):873-898
pubmed: 28668224
Nat Chem Biol. 2008 Mar;4(3):203-13
pubmed: 18246061
J Am Chem Soc. 2006 May 3;128(17):5616-7
pubmed: 16637611
Methods Mol Biol. 2017;1491:145-159
pubmed: 27778287
Science. 2002 Dec 6;298(5600):2002-6
pubmed: 12471262
J Biol Chem. 2004 Oct 8;279(41):43000-7
pubmed: 15304495
Br J Clin Pharmacol. 2017 Dec;83(12):2813-2820
pubmed: 28800383
J Biol Chem. 2000 Sep 15;275(37):29000-10
pubmed: 10887194
Clin Pharmacol Ther. 2018 Dec;104(6):1155-1164
pubmed: 29484635
FEBS J. 2019 Oct;286(20):3998-4023
pubmed: 31177613
Mol Cell Proteomics. 2016 Oct;15(10):3243-3255
pubmed: 27432909
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
Annu Rev Biochem. 2014;83:249-73
pubmed: 24905783
Chem Biol. 2000 Aug;7(8):569-81
pubmed: 11048948
Pharmacol Ther. 2017 Dec;180:49-61
pubmed: 28579388
Methods Cell Biol. 1994;45:213-20
pubmed: 7707987
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8721-6
pubmed: 15166288
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Biochem J. 2001 Dec 1;360(Pt 2):481-9
pubmed: 11716777
Nat Rev Drug Discov. 2010 Sep;9(9):690-701
pubmed: 20811381
Pharmacol Ther. 2018 Oct;190:202-236
pubmed: 29842917
Mol Biochem Parasitol. 2006 Nov;150(1):96-106
pubmed: 16890302
Antimicrob Agents Chemother. 2013 Oct;57(10):4645-52
pubmed: 23836185
PLoS Pathog. 2017 Sep 18;13(9):e1006586
pubmed: 28922424
Exp Parasitol. 2006 Mar;112(3):187-92
pubmed: 16337629
PLoS Pathog. 2018 May 16;14(5):e1007031
pubmed: 29768491
Chem Biol. 2010 Aug 27;17(8):808-19
pubmed: 20797610